We have one of the largest clusters of academic clinical nephrologists in Canada, with 42 full-time and 32 part-time and adjunct clinical faculty.
Our staff are dedicated to expanding the knowledge base of causes, treatments, and cures for kidney disease; to provide unparalleled care to patients; and to train the next generation of nephrologist practitioners and scientists. The depth of expertise and accomplishments of faculty, and the breadth and rigor of training and research activities, as well as internationally acclaimed sub-specialties, serve to highlight the vigor of the division.
-
2023
Atypical Polycystic Kidney Disease as Defined by Imaging
-
2023
Preclinical Evaluation of Tolvaptan and Salsalate Combination Therapy in a Pkd1-Mouse Model
-
2022
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial
-
2022
Urinary Epidermal Growth Factor/Monocyte Chemotactic Peptide 1 Ratio as Non-invasive Predictor of Mayo Clinic Imaging Classes in Autosomal Dominant Polycystic Kidney Disease
-
2022
The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD
-
2022
Safety of High-Dose 3% Sodium Tetradecyl Sulfate for Sclerotherapy of Renal Cysts in Patients with Autosomal Dominant Polycystic Kidney Disease